HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.59

EPS Forecast

$369

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$1.59

Revenue Forecast:

$369

EPS Surprise Forecast:

$0.037

Revenue Surprise Forecast:

$4

Post-release price volatility - High

Post-release Overnight Move:

±7.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

63%

Probability of beating revenue consensus:

63%

Probability of beating both EPS & revs consensus:

46%

Probability of missing both EPS & revs consensus:

21%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.55

Earnings volatility

EPS standard deviation:

$0.33

Revenue standard deviation:

$26

As % of share price:

0.52% HIGH

As % of market cap:

0.35% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$2.03

Revenue 95th %ile:

$404

EPS 75th %ile:

$1.71

Revenue 75th %ile:

$379

EPS 25th %ile:

$1.50

Revenue 25th %ile:

$361

EPS 5th %ile:

$1.25

Revenue 5th %ile:

$340

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

67% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$13

Bid-ask per Share:

$0.08